Handelsbanken Fonder AB - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 38 filers reported holding AC IMMUNE SA in Q4 2022. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2023$288
-3.7%
101,0640.0%0.00%0.0%
Q2 2023$299
+26.7%
101,0640.0%0.00%
+100.0%
Q1 2023$236
+14.6%
101,0640.0%0.00%0.0%
Q4 2022$206
-99.9%
101,0640.0%0.00%
-50.0%
Q3 2022$319,000
-12.6%
101,0640.0%0.00%0.0%
Q2 2022$365,000
-9.7%
101,0640.0%0.00%0.0%
Q1 2022$404,000101,0640.00%
Other shareholders
AC IMMUNE SA shareholders Q4 2022
NameSharesValueWeighting ↓
BVF INC/IL 7,428,379$21,170,8800.57%
Avidity Partners Management LP 2,969,800$8,463,9300.34%
PLATINUM INVESTMENT MANAGEMENT LTD 1,322,462$3,769,0170.15%
Eversept Partners, LP 124,589$355,0790.03%
COHEN LAWRENCE B 12,850$36,6230.02%
Banque Cantonale Vaudoise 80,701$2310.01%
Renaissance Technologies 425,179$1,2120.00%
Handelsbanken Fonder AB 101,064$2880.00%
Tower Research Capital LLC (TRC) 19,638$55,9680.00%
Compagnie Lombard Odier SCmA 10,000$28,5000.00%
View complete list of AC IMMUNE SA shareholders